We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.86B
AUM Growth
-$412M
Cap. Flow
+$88.2M
Cap. Flow %
1.81%
Top 10 Hldgs %
32.54%
Holding
208
New
15
Increased
86
Reduced
85
Closed
22

Top Buys

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$67.9M
2
LTH icon
Life Time Group Holdings
LTH
+$64.3M
3
CHGG icon
Chegg
CHGG
+$42.3M
4
ENVX icon
Enovix
ENVX
+$41.2M
5
EEFT icon
Euronet Worldwide
EEFT
+$30.6M

Top Sells

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$60.1M
2
GTLS
Chart Industries
GTLS
+$52M
3
WK icon
Workiva
WK
+$40M
4
KRNT icon
Kornit Digital
KRNT
+$30.5M
5
RSKD icon
Riskified
RSKD
+$25.7M

Sector Composition

Rank Sector Weight
1 Technology 35.92%
2 Healthcare 18.43%
3 Industrials 16.38%
4 Consumer Discretionary 12.45%
5 Financials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DH icon
126
Definitive Healthcare
DH
$73.7M
$8.15M 0.17%
+298,385
New +$10.4M
HDSN
127
Hudson Technologies
HDSN
$240M
$8.12M 0.17%
1,828,960
-146,260
-7% -$567K
ATRC icon
128
AtriCure
ATRC
$2.12B
$7.95M 0.16%
114,287
-4,588
-4% -$333K
FATE icon
129
Fate Therapeutics
FATE
$322M
$7.8M 0.16%
133,401
+58,909
+79% +$3.34M
NTNX icon
130
Nutanix
NTNX
$17.4B
$7.72M 0.16%
242,370
-26,136
-10% -$896K
AKTS
131
DELISTED
Akoustis Technologies Inc
AKTS
$7.65M 0.16%
1,144,540
+243,540
+27% +$1.82M
AXTI icon
132
AXT Inc
AXTI
$4.83B
$7.36M 0.15%
835,405
+74,636
+10% +$631K
KNSA icon
133
Kiniksa Pharmaceuticals
KNSA
$5.97B
$7.06M 0.15%
599,522
+193,688
+48% +$2.38M
XENE icon
134
Xenon Pharmaceuticals
XENE
$6.21B
$6.79M 0.14%
217,301
+133,447
+159% +$3.99M
NEWR
135
DELISTED
New Relic, Inc.
NEWR
$6.77M 0.14%
61,533
+3,061
+5% +$295K
BEAM icon
136
Beam Therapeutics
BEAM
$2.82B
$6.65M 0.14%
83,392
-7,448
-8% -$638K
PLSE icon
137
Pulse Biosciences
PLSE
$2.96B
$6.45M 0.13%
435,160
+69,395
+19% +$1.38M
SLAB icon
138
Silicon Laboratories
SLAB
$7.2B
$6.34M 0.13%
30,728
-3,134
-9% -$577K
QLYS icon
139
Qualys
QLYS
$6.43B
$6.33M 0.13%
46,132
-640
-1% -$81.8K
SMED
140
DELISTED
Sharps Compliance Corp
SMED
$6.09M 0.13%
854,585
+103,531
+14% +$795K
CTG
141
DELISTED
Computer Task Group, Inc.
CTG
$6.09M 0.13%
610,904
+71,031
+13% +$600K
SPRO icon
142
Spero Therapeutics
SPRO
$71.2M
$6.07M 0.12%
378,932
-176,682
-32% -$2.81M
PTC icon
143
PTC
PTC
$16.4B
$6.03M 0.12%
49,742
+4,449
+10% +$536K
RCUS icon
144
Arcus Biosciences
RCUS
$3.66B
$5.56M 0.11%
137,387
+32,539
+31% +$1.26M
WDC icon
145
Western Digital
WDC
$151B
$5.54M 0.11%
112,429
+58,216
+107% +$2.53M
CALY
146
Callaway Golf Company
CALY
$3.04B
$5.5M 0.11%
200,499
+127,392
+174% +$3.54M
BPMC
147
DELISTED
Blueprint Medicines
BPMC
$5.43M 0.11%
50,725
-2,072
-4% -$217K
HLIT icon
148
Harmonic Inc
HLIT
$1.26B
$5.42M 0.11%
+461,213
New +$4.75M
AIRG icon
149
Airgain
AIRG
$71.7M
$5.36M 0.11%
504,262
+28,891
+6% +$311K
HSKA
150
DELISTED
Heska Corp
HSKA
$5.08M 0.1%
27,843
+8,238
+42% +$1.64M
4 5
6
7 8

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Granahan Investment Management held 208 positions worth $4.86B, down 7.8% from $5.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management's Q4 2021 filing shows 15 new, 86 increased, 85 reduced and 22 closed positions. Its largest new stake was Stratasys: 2,436,279 shares worth $59.7M. The largest sale was Enphase Energy, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q4 2021 buy was Stratasys: 2,436,279 shares worth $59.7M.
  • Granahan Investment Management added most to Chegg in Q4 2021, an estimated $42.3M increase.
  • Granahan Investment Management's biggest Q4 2021 reduction was Enphase Energy, cutting an estimated $60.1M.
  • Granahan Investment Management fully exited Riskified in Q4 2021, selling an estimated $25.7M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $4.86B portfolio in Q4 2021.
  • Granahan Investment Management opened 15 new positions and closed 22 in Q4 2021.
  • Granahan Investment Management's portfolio value fell 7.8% quarter-over-quarter to $4.86B.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.